The estimated Net Worth of Mark A Buthman is at least $33.4 Million dollars as of 19 November 2015. Mr. Buthman owns over 5,988 units of West Pharmaceutical Services stock worth over $30,039,682 and over the last 21 years he sold WST stock worth over $3,083,366. In addition, he makes $306,787 as Independent Director at West Pharmaceutical Services.
Mark has made over 31 trades of the West Pharmaceutical Services stock since 2003, according to the Form 4 filled with the SEC. Most recently he sold 5,988 units of WST stock worth $730,536 on 19 November 2015.
The largest trade he's ever made was exercising 99,956 units of West Pharmaceutical Services stock on 30 January 2012 worth over $6,084,322. On average, Mark trades about 5,368 units every 40 days since 2003. As of 19 November 2015 he still owns at least 99,354 units of West Pharmaceutical Services stock.
You can see the complete history of Mr. Buthman stock trades at the bottom of the page.
Mark A. Buthman serves as Independent Director of the Company. Mr. Buthman retired from Kimberly-Clark Corporation—a global producer of branded products for the consumer, professional and healthcare markets—in December 2015, where he was Executive Vice President and Chief Financial Officer from January 2003 to April 2015. During his 33-year career at Kimberly-Clark, Mr. Buthman held a wide range of leadership roles in finance, strategy and operations, and led or participated in more than 50 acquisitions during his tenure as Chief Financial Officer. Mr. Buthman is a Board member of IDEX Corporation and Vice Chairman of the Board of Directors of Pavillon International.
As the Independent Director of West Pharmaceutical Services, the total compensation of Mark Buthman at West Pharmaceutical Services is $306,787. There are 15 executives at West Pharmaceutical Services getting paid more, with Eric Green having the highest compensation of $6,533,690.
Mark Buthman is 59, he's been the Independent Director of West Pharmaceutical Services since 2011. There are 8 older and 17 younger executives at West Pharmaceutical Services. The oldest executive at West Pharmaceutical Services, Inc. is Patrick Zenner, 73, who is the Independent Chairman of the Board.
Mark's mailing address filed with the SEC is 3100 SANDERS ROAD, SUITE 301, NORTHBROOK, IL, 60062.
Over the last 19 years, insiders at West Pharmaceutical Services have traded over $32,829,857 worth of West Pharmaceutical Services stock and bought 19,924 units worth $1,139,950 . The most active insiders traders include Robert F Friel, Paolo Pucci, and Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of $4,786,805. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth $308,700.
west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.
West Pharmaceutical Services executives and other stock owners filed with the SEC include: